Drugs / BIFICO
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02844426 | Sep 2015 → Jun 2016 | intestinal dysmotility syndrome | Jinling Hospital, China | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIFICO | “patients are allowed to take synbiotic (BIFICOPEC) contained 0.63g bifid triple viable capsule (BIFICO) and 8g soluble dietary fiber (Pectin) .” NCT02844426 ↗ |
| Known as | bifid triple viable capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02844426 ↗ |